September 2018 Issue Table Of Contents

From The Editor

• Nothing Ventured, Nothing Learned

Feature Articles

• One-On-One With Tony Coles, CEO Of Yumanity Therapeutics
• Our Annual Cancer Immuno-oncology Update 2018
• Why And How To Close The Gender Gap In The Life Sciences

Capitol Perspectives

• Democrats And Trump Focus On Pharmaceutical Pricing

CEO Corner

• My Life As A Recovering VC, Zigging Where Others Zag

From Principles and Policy to Execution

• The Business Model To Support Innovation And Access To New Therapies

Industry Research

• Department Influence On CMO Selection

Companies To Watch

• United Neuroscience

Inside The Industry

• A Hypothetical Question About Outsourcing Services Leads To … More Questions?
• Gene Therapy Pioneer’s 30 Years Of Problem-Solving
• How To Apply Lean and Agile Methodologies To Professional Services Procurement
• Novartis Turns To Digital Technologies For Clinical Trials
• Preparing a Promising Drug Candidate for ANDA Litigation
• From Big Pharma To Small Company Founder
• A New “Strategic Engine” For Developing Drugs, Diagnostics, & Devices

Leadership Lessons

• Is Your Network Getting Less Diverse As It Grows?

Ask The Board

• Where Should Biotech Companies Recruit Scientists For The Future, And How Should Universities Prepare Students To Be The Biotech Workforce For The Future?
• Are Patientless Clinical Trials A Reality Or A Fantasy?
• What Do You Look For In Board Members/Advisors?